Technology News and Research

RSS

DiaGenic third quarter income increases from NOK -9.3 million to NOK -9.6 million

DiaGenic: The interim report for the third quarter 2010 was approved by the Board of Directors on 28 October 2010.

29 Oct 2010

Researchers develop morpholino oligonucleotides that can turn off specific genes

Researchers at North Carolina State University have found a way to "cage" genetic off switches in such a way that they can be activated when exposed to UV light. Their technology gives scientists a more precise way to control and study gene function in localized areas of developing organisms.

29 Oct 2010

Physicians suggest tips to overcome acute pain

The truth is not all pain is created equal. Acute pain is where it all begins. Lasting for several months, acute pain is typically treated with rest, time and medication. For many, that is enough. But if the pain persists, it converts to chronic pain, and new methods must be explored.

29 Oct 2010

Stryker enters agreement to acquire assets of Neurovascular division of Boston Scientific

Stryker Corporation announced today a definitive agreement to acquire the assets of the Neurovascular division of Boston Scientific in an all cash transaction for $1.5 billion, which includes $100 million of milestone payments.

From Stryker 29 Oct 2010

IntriCon third quarter net sales increases 14% to $14.7 million

IntriCon Corporation a designer, developer, manufacturer and distributor of body-worn medical devices, today announced financial results for its third quarter ended September 30, 2010.

29 Oct 2010

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Geron Corporation today reported financial results for the three and nine months ended September 30, 2010.

29 Oct 2010

ImmunoGen first quarter net loss increases to $12.9 million

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended September 30, 2010 - the first quarter of the Company's 2011 fiscal year (1QFY11).

29 Oct 2010

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2010.

29 Oct 2010

Bioniche ranked #14 on Top 50 Best Small and Medium Employers in Canada

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, is pleased to be named among the Top 50 Best Small and Medium Employers in Canada. Bioniche was ranked number 14 by its employees. Two years ago, the Company attained a 13th place ranking.

28 Oct 2010

Palomar Medical Technologies third quarter revenues increase to $15.8 million

Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.

28 Oct 2010

Encision second quarter net sales decrease 11% to $2.87 million

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its second fiscal quarter ended September 30, 2010.

28 Oct 2010

Richmont establishes distribution of PURE's SDC-based IV-7 products in Middle East

PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.

28 Oct 2010

NeoGenomics third quarter revenue grows 19% to $8.7 million

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the third quarter 2010.

28 Oct 2010

FDA clears ArthroCare's Spartan PEEK Suture Implant system

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan PEEK Suture Implant system (Spartan™). Spartan is a preloaded PEEK threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

28 Oct 2010

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

The 4th International Symposium and Workshop on Virtual Interactive Musculoskeletal System, organized by National Cheng Kung University, Taiwanese Society of Biomechanics and Taiwanese Society of Biomechanics in Sports, is held on October 28th and 29th in International Conference Hall, Kuang-Fu Campus, National Cheng Kung University (NCKU), Tainan, Taiwan,

28 Oct 2010

PSS World Medical second quarter net sales decrease 11.7% to $496.2 million

PSS World Medical, Inc. announced today its results for the fiscal 2011 second quarter ended October 1, 2010.

28 Oct 2010

Transcend 2010 third quarter revenue increases 24% to $22,916,000

TRANSCEND SERVICES, INC. a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the third quarter ended September 30, 2010.

28 Oct 2010

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in Bogota, Colombia presented the results of the Center's first 95 fertility treatment cycles utilizing INVO Bioscience's INVOcell for couples with fertility issues at the 66th Annual Meeting of the American Society of Reproductive Medicine (ASRM) in Denver.

28 Oct 2010

Max Planck Innovation licenses new software for metabolite analysis

Max Planck Innovation licenses analysis-technology for metabolites . Max Planck Innovation GmbH, the technology transfer organization of the Max Planck Society, has awarded an exclusive license for the analysis software TagFinder to Metabolomic Discoveries GmbH, a service provider in biochemical research.

28 Oct 2010

Samplify introduces new SMK9130 Ultrasound Beamforming Development Kit

Samplify Systems, Inc., a leading provider of innovative beamforming technology, analog-front-end semiconductors and solutions for the medical imaging market, today introduces its new SMK9130 Ultrasound Beamforming Development Kit. Based on Samplify's AutoFocus™ beamforming technology, the SMK9130 is a complete hardware solution for the ultrasound front end, from probe connector to PCIe connector.

28 Oct 2010